Sientra Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
19,125.00
5,811.00
41,230.00
40,166.00
64,028.00
82,627
Depreciation, Depletion & Amortization
280.00
275.00
318.00
1,177.00
3,034.00
3,321
Other Funds
-
3,107.00
714.00
-
725.00
20,279
Funds from Operations
13,843.00
1,998.00
22,139.00
33,597.00
48,035.00
59,035
Changes in Working Capital
12,034.00
2,448.00
3,955.00
833.00
2,119.00
2,845
Net Operating Cash Flow
25,877.00
450.00
18,184.00
34,430.00
45,916.00
56,190
Capital Expenditures
71.00
439.00
1,128.00
1,126.00
1,864.00
Net Investing Cash Flow
18,071.00
439.00
1,128.00
12,835.00
20,319.00
Issuance/Reduction of Debt, Net
14,712.00
9,852.00
26,625.00
-
24,343.00
Net Financing Cash Flow
14,462.00
86,996.00
35,384.00
1,676.00
25,611.00
Net Change in Cash
29,486.00
87,007.00
16,072.00
45,589.00
40,624.00
Free Cash Flow
25,948.00
11.00
19,312.00
35,556.00
47,780.00
Deferred Taxes & Investment Tax Credit
-
-
-
61.00
21.00
8
Net Assets from Acquisitions
-
-
-
11,709.00
18,455.00
Change in Capital Stock
250.00
80,251.00
62,723.00
1,676.00
1,993.00
Other Uses
18,000.00
-
-
-
-

About Sientra

View Profile
Address
420 South Fairview Avenue
Santa Barbara California 93117
United States
Employees -
Website http://www.sientra.com
Updated 07/08/2019
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders. The company was founded by Hani M.